Discovery of the FLT3 inhibitor gilteritinib as a novel therapeutic strategy to overcome ALK-TKI resistanceHayato Mizuta,Ai Takemoto,Satoshi Takagi,Siro Simizu,Makoto Nishio,Naoya Fujita,Ryohei KatayamaCANCER SCIENCE(2022)引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要